rejuvesol

Generic: sodium pyruvate, inosine, adenine, sodium phosphate, dibasic, and sodium phosphate, monobasic, monohydrate

Labeler: citra labs, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name rejuvesol
Generic Name sodium pyruvate, inosine, adenine, sodium phosphate, dibasic, and sodium phosphate, monobasic, monohydrate
Labeler citra labs, llc
Dosage Form SOLUTION
Routes
EXTRACORPOREAL
Active Ingredients

adenine .034 g/50mL, inosine 1.34 g/50mL, sodium phosphate, dibasic .73 g/50mL, sodium phosphate, monobasic, monohydrate .311 g/50mL, sodium pyruvate .55 g/50mL

Manufacturer
Citra Labs, LLC

Identifiers & Regulatory

Product NDC 23731-7000
Product ID 23731-7000_f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number BN950522
Listing Expiration 2026-12-31
Marketing Start 1997-02-26

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 237317000
Hyphenated Format 23731-7000

Supplemental Identifiers

UNII
JAC85A2161 5A614L51CT GR686LBA74 593YOG76RN POD38AIF08

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rejuvesol (source: ndc)
Generic Name sodium pyruvate, inosine, adenine, sodium phosphate, dibasic, and sodium phosphate, monobasic, monohydrate (source: ndc)
Application Number BN950522 (source: ndc)
Routes
EXTRACORPOREAL
source: ndc

Resolved Composition

Strengths
  • .034 g/50mL
  • 1.34 g/50mL
  • .73 g/50mL
  • .311 g/50mL
  • .55 g/50mL
source: ndc
Packaging
  • 12 VIAL, SINGLE-USE in 1 CASE (23731-7000-5) / 50 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (1)

23731-7000-5 12 VIAL, SINGLE-USE in 1 CASE (23731-7000-5) / 50 mL in 1 VIAL, SINGLE-USE

Ingredients (5)

adenine (.034 g/50mL) inosine (1.34 g/50mL) sodium phosphate, dibasic (.73 g/50mL) sodium phosphate, monobasic, monohydrate (.311 g/50mL) sodium pyruvate (.55 g/50mL)

Linked Drug Pages (1)

Rejuvesol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["EXTRACORPOREAL"], "spl_id": "f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2", "openfda": {"unii": ["JAC85A2161", "5A614L51CT", "GR686LBA74", "593YOG76RN", "POD38AIF08"], "spl_set_id": ["bc06c40f-81a0-45e5-80b6-61f67d445068"], "manufacturer_name": ["Citra Labs, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 VIAL, SINGLE-USE in 1 CASE (23731-7000-5)  / 50 mL in 1 VIAL, SINGLE-USE", "package_ndc": "23731-7000-5", "marketing_start_date": "19970226"}], "brand_name": "Rejuvesol", "product_id": "23731-7000_f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2", "dosage_form": "SOLUTION", "product_ndc": "23731-7000", "generic_name": "Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate", "labeler_name": "Citra Labs, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rejuvesol", "active_ingredients": [{"name": "ADENINE", "strength": ".034 g/50mL"}, {"name": "INOSINE", "strength": "1.34 g/50mL"}, {"name": "SODIUM PHOSPHATE, DIBASIC", "strength": ".73 g/50mL"}, {"name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE", "strength": ".311 g/50mL"}, {"name": "SODIUM PYRUVATE", "strength": ".55 g/50mL"}], "application_number": "BN950522", "marketing_category": "NDA", "marketing_start_date": "19970226", "listing_expiration_date": "20261231"}